Challenges Facing Antimicrobial Stewardship Programs in the Endemic Region for Coccidioidomycosis.

antifungal agents antifungal stewardship antimicrobial stewardship coccidioidomycosis diagnostic stewardship

Journal

Open forum infectious diseases
ISSN: 2328-8957
Titre abrégé: Open Forum Infect Dis
Pays: United States
ID NLM: 101637045

Informations de publication

Date de publication:
Jun 2024
Historique:
received: 09 11 2023
accepted: 23 01 2024
medline: 18 6 2024
pubmed: 18 6 2024
entrez: 18 6 2024
Statut: epublish

Résumé

Coccidioidomycosis poses a significant cost and morbidity burden in the United States. Additionally, coccidioidomycosis requires constant decision-making related to prevention, diagnosis, and management. Delays in diagnosis lead to significant consequences, including unnecessary diagnostic workup and antibacterial therapy. Antifungal stewardship considerations regarding empiric, prophylactic, and targeted management of coccidioidomycosis are also complex. In this review, the problems facing antimicrobial stewardship programs (ASPs) in the endemic region for coccidioidomycosis, consequences due to delayed or missed diagnoses of coccidioidomycosis on antibacterial prescribing, and excess antifungal prescribing for prevention and treatment of coccidioidomycosis are elucidated. Finally, our recommendations and research priorities for ASPs in the endemic region for coccidioidomycosis are outlined.

Identifiants

pubmed: 38887479
doi: 10.1093/ofid/ofae041
pii: ofae041
pmc: PMC11181196
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

ofae041

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America.

Déclaration de conflit d'intérêts

Potential conflicts of interest. J. F. H. has received research support from Mayne Pharma. D. E. N. reports no potential conflicts.

Références

Med Mycol. 2018 Oct 1;56(7):900-902
pubmed: 29228363
Clin Infect Dis. 2021 Oct 5;73(7):e1587-e1593
pubmed: 32511677
Am J Transplant. 2013 Apr;13(4):1034-1039
pubmed: 23399074
Clin Transplant. 2019 Sep;33(9):e13553
pubmed: 30924967
JAMA. 2016 May 3;315(17):1864-73
pubmed: 27139059
Open Forum Infect Dis. 2023 Jul 10;10(8):ofad345
pubmed: 37539063
Vaccine. 2021 Nov 16;39(47):6894-6901
pubmed: 34696935
mSphere. 2018 May 16;3(3):
pubmed: 29769377
Pediatrics. 2022 Jul 1;150(1):
pubmed: 35703030
Antimicrob Agents Chemother. 2017 Mar 24;61(4):
pubmed: 28096163
Am J Transplant. 2011 Jan;11(1):111-9
pubmed: 21087416
JAMA Netw Open. 2018 Jun 1;1(2):e180243
pubmed: 30646067
Clin Infect Dis. 2016 Sep 15;63(6):e112-46
pubmed: 27470238
Infect Control Hosp Epidemiol. 2022 Dec;43(12):1965-1966
pubmed: 34553680
Mycopathologia. 2006 Jan;161(1):21-6
pubmed: 16389480
Antimicrob Steward Healthc Epidemiol. 2023 May 04;3(1):e89
pubmed: 37179757
Antimicrob Agents Chemother. 2019 Feb 26;63(3):
pubmed: 30559134
J Fungi (Basel). 2023 May 11;9(5):
pubmed: 37233265
Clin Transplant. 2016 Nov;30(11):1377-1386
pubmed: 27581783
Lancet. 2022 Feb 12;399(10325):629-655
pubmed: 35065702
Open Forum Infect Dis. 2022 May 11;9(7):ofac234
pubmed: 35873300
Clin Infect Dis. 1993 Mar;16(3):349-54
pubmed: 8452945
Clin Infect Dis. 2024 Jun 14;78(6):1559-1563
pubmed: 37802909
Infect Control Hosp Epidemiol. 2023 Dec;44(12):1901-1908
pubmed: 37665212
Acta Anaesthesiol Belg. 2011;62(2):105-8
pubmed: 21919379
Clin Infect Dis. 2023 Jun 16;76(12):2196-2199
pubmed: 36905151
Open Forum Infect Dis. 2021 Jan 18;8(2):ofab020
pubmed: 33575429
Mycopathologia. 2007 Jun;163(6):315-9
pubmed: 17484074
Open Forum Infect Dis. 2023 Aug 01;10(9):ofad412
pubmed: 37674632
Emerg Infect Dis. 2008 Jul;14(7):1053-9
pubmed: 18598625
Transpl Infect Dis. 2003 Mar;5(1):3-8
pubmed: 12791068
Mycoses. 2018 Nov;61(11):796-813
pubmed: 30098069
Ann N Y Acad Sci. 2007 Sep;1111:434-41
pubmed: 17513463
JAMA Netw Open. 2023 May 1;6(5):e2313011
pubmed: 37166794
Clin Infect Dis. 2020 Sep 12;71(6):1367-1376
pubmed: 31802125
Clin Infect Dis. 2011 Dec;53(11):1060-6
pubmed: 22045955
Am J Transplant. 2019 Sep;19(9):2517-2524
pubmed: 30811848
Open Forum Infect Dis. 2023 Jan 31;10(1):ofac654
pubmed: 36733697
Med Mycol. 2011 Aug;49(6):649-56
pubmed: 21247229
JCI Insight. 2022 Nov 22;7(22):
pubmed: 36166305
BMJ Open. 2021 Feb 18;11(2):e045605
pubmed: 33602715
Med Mycol. 2005 May;43(3):281-4
pubmed: 16010855
J Infect Dis. 1996 May;173(5):1273-7
pubmed: 8627085
J Antimicrob Chemother. 2019 Mar 1;74(3):768-771
pubmed: 30535104
Med Mycol. 2020 Apr 1;58(3):411-413
pubmed: 31290546
Med Mycol. 2019 Feb 1;57(Supplement_1):S30-S40
pubmed: 30690599
Am J Transplant. 2022 Jan;22(1):96-112
pubmed: 34212491
Emerg Infect Dis. 2009 Mar;15(3):397-401
pubmed: 19239751
Mycopathologia. 2006 Nov;162(5):317-24
pubmed: 17123029
Med Mycol. 2019 Feb 1;57(Supplement_1):S76-S84
pubmed: 30690601
Clin Infect Dis. 2020 Apr 15;70(9):2008-2012
pubmed: 31544210
Emerg Infect Dis. 2019 Aug;25(9):1742-1744
pubmed: 31228403
Emerg Infect Dis. 2019 Sep;25(9):1745-1747
pubmed: 31441755
MMWR Surveill Summ. 2022 Aug 19;71(7):1-14
pubmed: 36006889
J Clin Microbiol. 2023 May 23;61(5):e0158122
pubmed: 36883820
Med Mycol. 2019 Feb 1;57(Supplement_1):S56-S63
pubmed: 29669037
Antimicrob Agents Chemother. 2019 Jan 29;63(2):
pubmed: 30455235
Int J Dermatol. 2019 Feb;58(2):250-253
pubmed: 30229876
Antimicrob Steward Healthc Epidemiol. 2022 Dec 22;1:
pubmed: 35910521
Am J Transplant. 2006 Feb;6(2):340-5
pubmed: 16426318
J Infect Dis. 2020 Aug 5;222(Suppl 3):S175-S198
pubmed: 32756879
Emerg Infect Dis. 2018 Apr;24(4):779-781
pubmed: 29553315
Clin Diagn Lab Immunol. 2005 Jun;12(6):700-4
pubmed: 15939743
Clin Infect Dis. 2020 Apr 10;70(8):1781-1787
pubmed: 31641768
Jt Comm Perspect. 2016 Jul;36(7):1, 3-4, 8
pubmed: 27548932
Transpl Infect Dis. 2017 Oct;19(5):
pubmed: 28695649
Europace. 2017 Jul 01;19(7):1244-1249
pubmed: 27189953
Med Mycol. 2023 Nov 6;61(11):
pubmed: 37863836
Emerg Infect Dis. 2006 Jun;12(6):958-62
pubmed: 16707052
J Endocr Soc. 2019 Jun 06;3(7):1361-1366
pubmed: 31286100
Pharmacotherapy. 1990;10(6 ( Pt 3)):170S-173S
pubmed: 2075118
Rev Infect Dis. 1990 Mar-Apr;12 Suppl 3:S327-33
pubmed: 2330488

Auteurs

Justin F Hayes (JF)

Division of Infectious Diseases, University of Arizona, Tucson, Arizona, USA.
Valley Fever Center for Excellence, University of Arizona, Tucson, Arizona, USA.

David E Nix (DE)

Valley Fever Center for Excellence, University of Arizona, Tucson, Arizona, USA.
Department of Pharmacy Practice and Science, University of Arizona, Tucson, Arizona, USA.

Classifications MeSH